Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2014

Mar 19, 2014

33090_dirs_2014-03-19_82527bff-4d9a-4d42-ad11-9a37739ebef1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-03-13

Reporting Person: Radoff Bradley Louis (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.001 per share 3250000 Direct